Observational studyFrontiers in immunology2026
Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports.
Jinyi Tao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.